General Updates

Date: 14th August, 2026 To, To, The Manager (Listing) Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400051 BSE Scrip Code: 506260 NSE Symbol: ANUHPHR; Series: EQ Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015). Dear Sir, Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 and further to our intimation dated 20th May, 2026 we wish to inform you that the members of Anuh Pharma Limited (“the Company”) at the 66th Annual General Meeting of the Company inter alia, have considered and approved: 1. Reappointment of Mr. Bipin Nemchand Shah (DIN: 00083244) and Mr. Arun Lalchand Todarwal (DIN: 00020916) as Non-Executive Non-Independent Director of the Company, who were liable to retire by rotation being re-appointed in terms of Section 152(6) of the Companies Act, 2013 w.e.f. 12th August, 2026. The details as required are provided in Annexure – A and Annexure – B to this letter. 2. Reappointment of Mr. Ankit Kishor Chande, Cost Accountants (Certificate of Practice No. 34051) as a Cost Auditor for the financial year ending March, 2027. The details as required are provided in Annexure – C to this letter. 3. Revision in remuneration payable to Mr. Ritesh B. Shah (DIN: 02496729), Joint Managing Director of the Company for the financial year 2026-27. 4. Revision in remuneration payable to Mr. Vivek Shah (DIN: 02878724), Joint Managing Director of the Company for the financial year 2026-27. 5. Approval of Adoption of new set of Memorandum of Association (“MOA”) of the Company as per Companies Act, 2013, subject to approval of the shareholders. 6. Approval of Adoption of new set of Articles of Association (“AOA”) of the Company as per Companies Act, 2013, subject to approval of the shareholders. The above information is also available on the website of the Company www.anuhpharma.com. You are requested to kindly take the same on record. Thanking you, Yours faithfully, FOR ANUH PHARMA LIMITED MANAN VADHAN COMPANY SECRETARY & COMPLIANCE OFFICER Place: Mumbai Annexure - A Details under amended Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sr. Details of events that need to be Information of such events No. Provided a) reason for change viz. appointment, Mr. Bipin Nemchand Shah (DIN: re-appointment, resignation, 00083244), has been re-appointed as removal, death or otherwise Non-Executive Non-Independent Director, who was liable to retire by rotation being re-appointed in terms of Section 152 (6) of the Companies Act, 2013. b) date of appointment / re- The members at its meeting held on appointment/ cessation (as August 12, 2026, has approved the re- applicable) appointment of Mr. Bipin Nemchand Shah (DIN: 00083244), as Non-Executive Non- Independent Director. c) term of appointment / re- Re-appointed as per the provisions of appointment Section 152(6) of the Companies Act, 2013. d) brief profile (in case of appointment) Mr. Bipin Shah is a Chemical Engineer by qualification. He is the Vice Chairman of Anuh Pharma Ltd., a leading bulk drug manufacturing Company and is also Director / Partner in other SK Group of Companies / Firms, who are in the pharmaceutical industry since last 90 years and he is responsible for distribution, C & F and Mother Depot operations of the group. He has a vast experience of nearly 50 years in the pharmaceutical field and is widely travelled. His specific area of interest has been marketing and management. He is currently the President of Thane Belapur Industries Association and he is a Managing Committee Member of Indian Merchant Chambers, Mumbai. e) disclosure of relationships between Mr. Bipin Shah is brother of Mr. Bharat directors (in case of appointment Shah (Non-Executive Director). of a director) Mr. Bipin Shah is father of Mr. Ritesh Shah (Joint Managing Director) and Mr. Vivek Shah (Joint Managing Director). f) Information as required under Mr. Bipin Shah is not debarred from Circular No. LIST/COMP/14/2018- holding the office of Director by virtue of 19 and NSE/CML/ 2018/02 dated any SEBI Order or any other such June 20, 2018 issued by the BSE and authority. NSE, respectively Annexure – B Details under amended Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sr. Details of events that need to be Information of such events No. Provided a) reason for change viz. appointment, Mr. Arun Todarwal (DIN: 00020916), has re-appointment, resignation, been re-appointed as Non-Executive Non- removal, death or otherwise Independent Director, who was liable to retire by rotation being re-appointed in terms of Section 152 (6) of the Companies Act, 2013. b) date of appointment / re- The members at its meeting held on appointment/ cessation (as August 12, 2026, has approved the re- applicable) appointment of Mr. Arun Todarwal (DIN: 00083354), as Non-Executive Non- Independent Director. c) term of appointment / re- Re-appointed as per the provisions of appointment Section 152(6) of the Companies Act, 2013. d) brief profile (in case of appointment) Mr. Arun Todarwal is a fellow member of the Institute of Chartered Accountants of India. He has been practicing as a Chartered Accountant since 1981. During his years of practice, he has handled various professional assignments including Statutory Audits, Internal Audits, Management and Systems Audits, Due diligences, Taxation, International Taxation, Joint Ventures, etc. He is well- versed in Tax matters and has travelled abroad on several occasions to deliver talks on Indian Taxation as well as Investment in India. Mr. Arun Todarwal is also a member of the Institute of Internal Auditors, National Centre for Quality Management, Bombay Management Association and Bombay Chartered Accountants Society. His vast experience has put him on panel of Auditors with the Registrar of Co-operatives Societies and the Official Liquidator, Mumbai High court. e) disclosure of relationships between There is no inter-se relationship among directors (in case of appointment the Directors. of a director) f) Information as required under Mr. Arun Todarwal is not debarred from Circular No. LIST/COMP/14/2018- holding the office of Director by virtue of 19 and NSE/CML/ 2018/02 dated any SEBI Order or any other such June 20, 2018 issued by the BSE and authority. NSE, respectively Annexure - C Details under amended Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sr. Details of events that need to be Information of such events No. Provided a) reason for change viz. appointment, Re-Appointment of Ankit Kishor Chande, re-appointment, resignation, Cost Accountants (Membership No.: removal, death or otherwise 34051; Firm Registration No.: 102660), as Cost Auditors of the Company. b) date of appointment / re- The members at its meeting held on August appointment/ cessation (as 12, 2026, has approved the re-appointment applicable) of Ankit Kishor Chande, Cost Accountant (Membership No.: 34051; Firm Registration No.: 102660). c) term of appointment / re- Ankit Kishor Chande, Cost Accountant are appointment re-appointed as Cost Auditor for the Financial Year 2026-27. d) brief profile (in case of Ankit Kishor Chande (Membership No.: appointment) 34051; Firm Registration No.: 102660) who is a Qualified Cost Accountant having his firm of Cost & Management Accountants registered with the Institute of Cost Accountants of India rendering services in the areas of Costing, Audit & Assurance, Consulting Advisory & Finance and has a total experience o [Showing first 8,000 characters — download PDF for full document]